Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Anesthetic Technique in NSCLC Surgery (Multicenter Study)
ChiCTR2000040604Phase 4Not yet recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sevoflurane and propofol in non-small cell lung cancer (NSCLC) (4 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: NRF2 expression, NLRP3 inflammasome and 3 more. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
sevofluranepropofol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2000040604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040604.